Transcriptional regulation of fibrillin-2 gene by E2F family members in chondrocyte differentiation

Journal of Cellular Biochemistry

Volumn 106, Issue 4, 2009, Pages 580-588

  Yanagino, Takuya ^a   Yuasa, Keizo ^a   Nagahama, Masami ^a   Matsuda, Yoshiko ^a   Tsuji, Akihiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Chondrogenesis; E2F; Extracellular matrix; Fibrillin 2; Transcriptional regulation

Indexed keywords

FIBRILLIN 1; FIBRILLIN 2; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR SOX; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVITY; ENZYME REGULATION; GENE DELETION; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHONDROCYTES; CHONDROGENESIS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F2 TRANSCRIPTION FACTOR; E2F3 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; MICE; MICROFILAMENT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 62649174136     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22029     Document Type: Article

References (38)

1. Arteaga-Solis E, Gayraud B, Lee SY, Shum L, Sakai L, Ramirez F. 2001. Regulation of limb patterning by extracellular microfibrils. J Cell Biol 154:275-281.
2. Beier F, Ali Z, Mok D, Taylor AC, Leask T, Albanese C, Pestell RG, LuValle P. 2001. TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol Biol Cell 12:3852-3863.
3. Carta L, Pereira L, Arteaga-Solis E, Lee-Arteaga SY, Lenart B, Starcher B, Merkel CA, Sukoyan M, Kerkis A, Hazeki N, Keene DR, Sakai LY, Ramirez F. 2006. Fibrillins 1 and 2 perform partially overlapping functions during aortic development. J Biol Chem 281:8016-8023.
4. Charbonneau NL, Ono RN, Corson GM, Keene DR, Sakai LY. 2004. Fine tuning of growth factor signals depends on fibrillin microfibril networks. Birth Defects Res C Embryo Today 72:37-50.
5. Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13:204-210.
6. Dong Y, Drissi H, Chen M, Chen D, Zuscik MJ, Schwarz EM, O'Keefe RJ. 2005. Wnt-mediated regulation of chondrocyte maturation: Modulation by TGF-beta. J Cell Biochem 95:1057-1068.
7. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J. 2002. E2Fs regulate adipocyte differentiation. Dev Cell 3:39-49.
8. Ferguson CM, Schwarz EM, Reynolds PR, Puzas JE, Rosier RN, O'Keefe RJ. 2000. Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation. Endocrinology 141:4728-4735.
9. Gregory KE, Ono RN, Charbonneau NL, Kuo CL, Keene DR, Bächinger HP, Sakai LY. 2005. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J Biol Chem 280:27970-27980.
10. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. 2006. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117-121.
11. Handford PA, Downing AK, Reinhardt DP, Sakai LY. 2000. Fibrillin: From domain structure to supramolecular assembly. Matrix Biol 19:457-470.
12. Hubmacher D, Tiedemann K, Reinhardt DP. 2006. Fibrillins: From biogenesis of microfibrils to signaling functions. Curr Top Dev Biol 75:93-123.
13. Ionescu AM, Schwarz EM, Zuscik MJ, Drissi H, Puzas JE, Rosier RN, O'Keefe RJ. 2003. ATF-2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation. Exp Cell Res 288:198-207.
14. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY. 2003. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 278:2750-2757.
15. Judge DP, Dietz HC. 2005. Marfan's syndrome. Lancet 366:1965-1976.
16. Kielty CM, Sherratt MJ, Shuttleworth CA. 2002. Elastic fibres. J Cell Sci 115:2817-2828.
17. Koide S, Yoshida I, Tsuji A, Matsuda Y. 2003. The expression of proprotein convertase PACE4 is highly regulated by Hash-2 in placenta: Possible role of placenta-specific basic helix-loop-helix transcription factor, human achaete-scute homologue-2. J Biochem 134:433-440.
18. Kozar K, Sicinski P. 2005. Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 4:388-391.
19. Kwon EJ, Oh EJ, Kim YS, Hirose F, Ohno K, Nishida Y, Matsukage A, Yamaguchi M, Yoo MA. 2001. E2F-dependent transcription of the raf proto-oncogene during Drosophila development. Nucleic Acids Res 29:1808-1814.
20. Li TF, Chen D, Wu Q, Chen M, Sheu TJ, Schwarz EM, Drissi H, Zuscik M, O'Keefe RJ. 2006. Transforming growth factor-beta stimulates cyclin D1 expression through activation of beta-catenin signaling in chondrocytes. J Biol Chem 281:21296-21304.
21. McClellan KA, Slack RS. 2007. Specific in vivo roles for E2Fs in differentiation and development. Cell Cycle 6:2917-2927.
22. Montero JA, Hurlé JM. 2007. Deconstructing digit chondrogenesis. Bioessays 29:725-737.
23. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. 2003. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407-411.
24. Pateder DB, Rosier RN, Schwarz EM, Reynolds PR, Puzas JE, D'Souza M, O'Keefe RJ. 2000. PTHrP expression in chondrocytes, regulation by TGF-beta, and interactions between epiphyseal and growth plate chondrocytes. Exp Cell Res 256:555-562.
25. Putnam EA, Zhang H, Ramirez F, Milewicz DM. 1995. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet 11:456-458.
26. Quondamatteo F, Reinhardt DP, Charbonneau NL, Pophal G, Sakai LY, Herken R. 2002. Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. Matrix Biol 21:637-646.
27. Ramirez F, Dietz HC. 2007. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events. J Cell Physiol 213:326-330.
28. Ramirez F, Sakai LY, Dietz HC, Rifkin DB. 2004. Fibrillin microfibrils: Multipurpose extracellular networks in organismal physiology. Physiol Genomics 19:151-154.
29. Rifkin DB. 2005. Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability. J Biol Chem 280:7409-7412.
30. Scheijen B, Bronk M, van der Meer T, Bernards R. 2003. Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation. Mol Cell Biol 23:3656-3668.
31. Sengle G, Charbonneau NL, Ono RN, Sasaki T, Alvarez J, Keene DR, Bächinger HP, Sakai LY. 2008. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem 283:13874-13888.
32. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
33. Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18:2699-2711.
34. Smith DB, Johnson KS. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
35. Stevens C, La Thangue NB. 2003. E2F and cell cycle control: A double-edged sword. Arch Biochem Biophys 412:157-169.
36. Viljoen D. 1994. Congenital contractural arachnodactyly (Beals syndrome). J Med Genet 31:640-643.
37. Yuasa K, Suzue K, Nagahama M, Matsuda Y, Tsuji A. 2007. Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: Possible role of E2F-mediated upregulation of PACE4 in tumor progression. Gene 402:103-110.
38. Zhang H, Hu W, Ramirez F. 1995. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol 129:1165-1176.